Useful Resources – New

What are Advanced Therapies Medicinal Products (ATMPs)?

  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View

Relevant EU Legislation

  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View

Literature

  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View

European Gene and Cell Therapy Database

  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View

Testing and diagnostics

  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View

Bringing ATMPs to the market

  • Research
  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View
  • Clinical development and manufacture
  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View
  • Regulatory affairs
  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View
  • Access to patients
  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View
  • Use of Real-World Evidence
  • Academic Article

    Placeholder Resource

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

    Read more ↓
    View

@TRANSFORM_CGT on Twitter Follow us →

RT @CancerPatientsE: 📣 We are calling for better use of real-world evidence to improve health outcomes! Join us and sign the Call to Action…
23 March at 4:09pm
Reply Retweet
RT @RWE4Decisions: Dr A Natz @EUCOPE shares the value of the multi-stakeholder collaboration in #RWE4Decisions and @TRANSFORM_CGT, key init…
23 March at 4:08pm
Reply Retweet
Today @ 🇪🇺 #HealthTechSummit, Dr.Natz @Eucope mentioned @TRANSFORM_CGT as a multi stakeholder platform fostering dialogue & providing recommendations on how to make the best possible use of #RWD to enable patient access to therapies ➡️see Charter Rec#3: https://t.co/XAeoSimAzh.
23 March at 4:08pm
Reply Retweet